Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity

H Zhang, J Vandesompele, K Braeckmans… - Chemical Society …, 2024 - pubs.rsc.org
Gene therapy is on its way to revolutionize the treatment of both inherited and acquired
diseases, by transferring nucleic acids to correct a disease-causing gene in the target cells …

Therapeutically significant microRNAs in primary and metastatic brain malignancies

AA Balachandran, LM Larcher, S Chen, RN Veedu - Cancers, 2020 - mdpi.com
Simple Summary The overall survival of brain cancer patients remains grim, with
conventional therapies such as chemotherapy and radiotherapy only providing marginal …

Bulge-forming miRNases cleave oncogenic miRNAs at the central loop region in a sequence-specific manner

O Patutina, D Chiglintseva, B Amirloo, D Clarke… - International Journal of …, 2022 - mdpi.com
The selective degradation of disease-associated microRNA is promising for the
development of new therapeutic approaches. In this study, we engineered a series of bulge …

Site-selective artificial ribonucleases: Renaissance of oligonucleotide conjugates for irreversible cleavage of rna sequences

Y Staroseletz, S Gaponova, O Patutina, E Bichenkova… - Molecules, 2021 - mdpi.com
RNA-targeting therapeutics require highly efficient sequence-specific devices capable of
RNA irreversible degradation in vivo. The most developed methods of sequence-specific …

Antisense oligonucleotide: a potential therapeutic intervention for chronic kidney disease

Y Li, Y Tan, R Zhang, T Wang, N Na, T Zheng… - Kidney and …, 2022 - mdpi.com
Chronic kidney disease (CKD) is a global public health issue that places an increasing
burden on the healthcare systems of both the developed and developing countries. CKD is a …